机构:[a]Department of Respiratory Medicine, Capital Medical University affiliated Bejjing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China临床科室呼吸内科首都医科大学附属安贞医院[b]Medical Informatics Center, Peking University, 38 Xueyuan Rd, Haidian District, Beijing, China
To evaluate the efectiveness and safety of interferon treatment for small cell lung cancer patients. Methods: We electronically searched the chinese academic journals database (1990-2012) and medline (1990-2012). Results: The meta-analysis included 5 trials from 86 studies, a total of 587 patients were included in the analysis. The results of meta-analyses showed that the IFN has no effective for 1 and 2 years survival time in small lung cancer patients (95%CI =1.19(0.88, 1.61) and (95%CI =1.44 (0.99, 2.10)). Conclusion: IFN has no effective for 1 and 2 years survival time in small lung cancer patients.
语种:
外文
中科院(CAS)分区:
出版当年[2012]版:
大类|4 区生物
小类|4 区生物学
最新[2023]版:
无
第一作者:
推荐引用方式(GB/T 7714):
Shang M,Xiao Z.A meta-analysis of therapy of small cell lung cancer with interferon[J].2013,10(4):
APA:
Shang, M&Xiao, Z.(2013).A meta-analysis of therapy of small cell lung cancer with interferon.,10,(4)
MLA:
Shang, M,et al."A meta-analysis of therapy of small cell lung cancer with interferon". 10..4(2013)